adalimumab-ryvk
Generic: adalimumab-ryvk
Labeler: quallent pharmaceuticals health llcDrug Facts
Product Profile
Brand Name
adalimumab-ryvk
Generic Name
adalimumab-ryvk
Labeler
quallent pharmaceuticals health llc
Dosage Form
KIT
Routes
Manufacturer
Identifiers & Regulatory
Product NDC
82009-156
Product ID
82009-156_e837767b-482a-487d-9d35-4516a8c25b3e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761299
Listing Expiration
2027-12-31
Marketing Start
2024-05-22
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
82009156
Hyphenated Format
82009-156
Supplemental Identifiers
RxCUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
adalimumab-ryvk (source: ndc)
Generic Name
adalimumab-ryvk (source: ndc)
Application Number
BLA761299 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 80 mg/0.8 ml
- 40 mg/0.4 ml
- 20 mg/0.2 ml
- 1 ml
Packaging
- 2 KIT in 1 CARTON (82009-156-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-157-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH (65517-0002-1)
Packages (1)
Ingredients (0)
No ingredient records.
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "e837767b-482a-487d-9d35-4516a8c25b3e", "openfda": {"rxcui": ["797544", "2677780", "2688826"], "spl_set_id": ["dce1590f-9e47-4c4d-9437-cfb18b779a75"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 KIT in 1 CARTON (82009-156-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-157-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH (65517-0002-1)", "package_ndc": "82009-156-22", "marketing_start_date": "20240522"}], "brand_name": "Adalimumab-ryvk", "product_id": "82009-156_e837767b-482a-487d-9d35-4516a8c25b3e", "dosage_form": "KIT", "product_ndc": "82009-156", "generic_name": "adalimumab-ryvk", "labeler_name": "Quallent Pharmaceuticals Health LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adalimumab-ryvk", "application_number": "BLA761299", "marketing_category": "BLA", "marketing_start_date": "20240522", "listing_expiration_date": "20271231"}